Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
Introduction: Recurrent metastatic choriocarcinoma is a rare disease with historically limited guidance in the literature regarding standardized treatment protocols. In this case report, we review the course of a patient with recurrent metastatic choriocarcinoma re-treated with single agent pembroli...
Saved in:
Main Authors: | Adriana J. Wong (Author), Lindsey Finch (Author), Joseph Matt Pearson (Author), Andre Pinto (Author), Marilyn Huang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous Manifestation of Metastatic Infantile Choriocarcinoma
by: Timothy Brooks, et al.
Published: (2014) -
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report
by: M. Lehmann, et al.
Published: (2023) -
Pulmonary Metastatic Choriocarcinoma in a Patient with Ectopic Pregnancy
by: Fahimeh Nokhostin, et al.
Published: (2017) -
Gestational choriocarcinoma complicated by infective endocarditis during chemotherapy
by: Tadaharu Nakasone, et al.
Published: (2017) -
A Case of Metastatic Vulvar Choriocarcinoma Misdiagnosed as Vulvar Abscess: A Case Report
by: Alita Mrema, et al.
Published: (2024)